Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Oct 25, 2011

Premium

Oxford Nanopore Technologies has hired Kristen Stoops as business development director. Stoops has more than 14 years of business development experience in life sciences technology companies, including a seven-year tenure with software firm Spotfire (now part of Tibco), where she directed all aspects of its commercial partner program in life sciences.

From 2006 to 2008, Stoops served as director of informatics business development at Helicos BioSciences, and following that she served as senior director of strategic marketing and new business development at Merck's Rosetta Biosoftware business unit. She also cofounded Neotron, a developer of nuclear detection technologies, in 2009. She holds an MA and a BA in physics.


Start-up nanopore sequencing company Genia has made public its management team. Stefan Roever is CEO. Roever is cofounder and former CEO of Brokat Technologies, an encryption banking software company. He is a private equity investor and serves as chairman of WRS Materials. He holds degrees in economics and law from the University of Tübingen in Germany.

Roger Chen, chief technical officer, has a background in analog-mixed signal electronics. He has worked at semiconductor firm Maxim Integrated Products and has launched more than 50 integrated circuits that are currently in production today. He holds a BS in electrical engineering from MIT and an MS in biochemistry from the University of California, Santa Cruz.

Randy Davis
is vice president of research and development. Previously, he worked at National Semiconductor and Maxim Integrated Products. He has also managed the University of California, San Francisco, Comprehensive Cancer Center's microarray and genomic analysis core labs. He holds an AA in electrical engineering and an MS in biology and business administration.

Pratima Rao
is vice president of marketing. She has held various senior management positions in both semiconductor and life science companies, including at Maxim Integrated Products and Affymetrix. She holds BS and MS degrees in electrical engineering from MIT and an MBA from Stanford University.


Illumina's senior vice president and chief commercial officer Tristan Orpin has joined GenoLogics' board of directors as part of a recent GenoLogics financing round, which was led by Illumina (see story, this issue). He has held several positions at Illumina since joining the company in 2002. Previously, he was vice president of sales and marketing at Sequenom, and also served in senior sales and marketing positions at Bio-Rad Laboratories. He holds a BS in genetics and biochemistry from the University of Melbourne.


Halo Genomics has appointed Mats Bergström to vice president of sales and John Lindsay as director of sales and marketing in North America.

Lindsay will serve as manager of the company's new offices in Cambridge, Mass. Lindsay has held senior management positions at Millipore, PerSeptive Biosystems, and Cohesive Technologies.

Bergström was most recently as a self-employed consultant in the life sciences. He has also held senior management positions at Pyrosequencing (now Qiagen) and Applied Biosystems (now Life Technologies).

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.